Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine
This completed clinical trial compares long-term use of galantamine versus unspecified memory-enhancing drugs in patients with Alzheimer's d…
-
CLINICAL_TRIALS trial_result · 2014-06-13Clinical Trial Update: Progression Delaying Effect of Escitalopram in Alzheimer's Disease [NA]
A completed clinical trial investigated whether escitalopram could delay progression in Alzheimer's disease; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease [Phase 1]
Phase 1 study evaluating the safety, tolerability, and blood levels of PF-03654746 in Alzheimer's disease was terminated, with results poste…
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease [Phase 4]
A Phase 4 clinical trial update from Florida Atlantic University examined delaying driving impairment in people with mild Alzheimer's diseas…
-
CLINICAL_TRIALS trial_result · 2014-05-29Clinical Trial Update: Phase 1 and Phase 2 Clinical Trials of SNUBH-NM-333(18F) [Phase 1, Phase 2]
Phase 1 and Phase 2 clinical trials of SNUBH-NM-333(18F) for Alzheimer's disease have been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period
An observational study evaluating the safety and effectiveness of Galantamine in patients with Alzheimer's disease over 18 months.
-
CLINICAL_TRIALS trial_result · 2014-05-13Clinical Trial Update: Cilostazol Augmentation Study in Dementia [Phase 4]
Phase 4 clinical trial results for cilostazol augmentation in Alzheimer's disease have been posted.
-
CLINICAL_TRIALS trial_result · 2014-05-13Clinical Trial Update: Effects of Sleep Deprivation on Cerebrospinal Fluid (CSF) Amyloid-beta (Aβ) Dynamics [NA]
This is a completed clinical trial investigating the effects of sleep deprivation on cerebrospinal fluid amyloid-beta dynamics in Alzheimer'…
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]
A Phase 2 trial evaluating the safety and amyloid imaging effects of subcutaneous bapineuzumab in mild-to-moderate Alzheimer's disease has c…
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheimer Disease [Phase 2]
Phase 2 study evaluating 123-I Iodobenzovesamicol (IBVM) with SPECT imaging in healthy subjects and patients with Alzheimer's disease and Pa…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 study of Octagam 10% intravenous immunoglobulin for mild-to-moderate Alzheimer's disease has completed, with results posted in 2014.…
-
CLINICAL_TRIALS trial_result · 2014-04-25Clinical Trial Update: Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
A Phase 2 safety and cognitive function trial of EVP-6124 (encenicline) in mild-to-moderate Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-23Clinical Trial Update: Safety and Tolerability of Etanercept in Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update evaluating the safety and tolerability of etanercept in Alzheimer's disease has been reported. The update summ…
-
CLINICAL_TRIALS trial_result · 2014-04-22Clinical Trial Update: Effects of Exercise Training in Patients With Mild Cognitive Impairment
A completed clinical trial investigating the effects of exercise training in patients with mild cognitive impairment, with Alzheimer's disea…
-
CLINICAL_TRIALS trial_result · 2014-04-22Clinical Trial Update: Cerebrospinal Fluid (CSF) Biomarkers Alzheimer's Disease (AD) and Non-AD Dementias
Clinical trial update reporting on a completed study evaluating cerebrospinal fluid biomarkers in Alzheimer's disease and non-Alzheimer's de…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Effects of Exercise Training in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease [NA]
Clinical trial update on the effects of exercise training in patients with Mild Cognitive Impairment and early Alzheimer's disease; the stud…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Effect of NeuroAD on Alzheimer Patients [NA]
Clinical trial update showing completion of a study evaluating NeuroAD in Alzheimer's disease; no results are provided in the snippet.
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Yogic Breathing Changes Salivary Components [NA]
This completed clinical trial examined whether yogic breathing changes salivary components.
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients [Phase 1]
This document reports the completion of a Phase 1 two-part multiple-dose study evaluating the safety and effects of AZD3293 (lanabecestat) i…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil [Phase 4]
Phase 4 trial assessing the efficacy and safety of galantamine in Alzheimer's disease patients who did not benefit from donepezil.
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: A Study to Measure CSF Proteins in Elderly Healthy Volunteers and Volunteers With Mild Cognitive Impairment or Alzheimer's Disease [EARLY_Phase 1]
This completed early-phase trial measured cerebrospinal fluid proteins in elderly healthy volunteers and participants with mild cognitive im…
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.
The study evaluates the COGNISION handheld ERP/qEEG system as a potential cognitive biomarker for Alzheimer's disease. The trial by Neuronet…
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain [Phase 1]
Phase 1 clinical trial evaluating 123I IMPY with SPECT imaging to detect beta-amyloid in the brain for Alzheimer's disease has been complete…
-
CLINICAL_TRIALS trial_result · 2014-03-03Clinical Trial Update: Treatment for Early Memory Loss [Phase 4]
A Phase 4 clinical trial addressing early memory loss has completed. The update does not provide the trial's results.
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: Effect of Exercises Training in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease [NA]
This update summarizes a completed clinical trial evaluating the effects of exercise training in people with mild cognitive impairment and e…